You are here:
LinkedIn-button

News

Check here for our latest news

Intravacc announces positive pre-clinical data for its OMV-based Lyme vaccine

Intravacc announces positive pre-clinical data for its OMV-based Lyme vaccine Bilthoven, the Netherlands, 13 April 2021 – Intravacc, a world leader in translational research and development of preventive and therapeutic vaccines, today announced positive preclinical data for its OMV based Lyme…

  • Neisserial OMV based Lyme vaccine elicit high antibody titers in mice
  • Further evidence for Intravacc's versatile multi-disease OMV platform
  • Data are published in peer reviewed journal Vaccine
Read more

Intravacc announces positive pre-clinical data for its SARS-CoV-2 nose spray vaccine

Intravacc announces positive pre-clinical data for its SARS-CoV-2 nose spray vaccine Bilthoven, the Netherlands, 7 April 2021 – Intravacc, a global leader in translational research and development of viral and bacterial vaccines, today announced that it has obtained positive pre-clinical results…

  • Intranasal administration of OMV-Spike protected against challenge with SARS-CoV-2
  • Intranasal vaccine administration has significant advantages over injectables
  • OMV technology is a powerful vaccine platform for future pandemics
Read more

Intravacc announces formation of Scientific Advisory Board

Intravacc announces formation of Scientific Advisory Board Bilthoven, the Netherlands, 23 February 2021 – Intravacc, a world leader in translational research and development of vaccines, today announced the formation of a Scientific Advisory Board (“SAB”), chaired by Intravacc’s Chief Scientific…

Read more

Intravacc neemt moderne pilot productiefaciliteit in gebruik en start concept-design van multifunctionele vaccinfabriek

Intravacc neemt moderne pilot productiefaciliteit in gebruik en start concept-design van multifunctionele vaccinfabriek Bilthoven, the Netherlands, 19 februari 2021 – Intravacc, wereldwijd vooraanstaand op het gebied van translationeel onderzoek naar en de ontwikkeling van vaccins, maakt bekend dat haar nieuwe moderne…

  • Pilotfabriek geschikt voor productie van vaccins in klinische fase I & II onderzoek
  • Consortium werkt plan uit voor nieuwe multifunctionele vaccinfabriek
  • Uitgebreide omgevingsvergunningen maken snelle realisatie mogelijk
Read more

Dutch Intravacc starts concept design for multifunctional, high-capacity vaccine plant for national requirement

Dutch Intravacc starts concept design for multifunctional, high-capacity vaccine plant for national requirement New state-of-the-art pilot vaccine production facility ready for use   Bilthoven, the Netherlands, 19 February 2021 – Intravacc, a world leader in translational research and development of…

  • New pilot plant for production of vaccine candidates in clinical phase I & II research
  • Consortium starts concept design for new multifunctional vaccine factory that can produce enough vaccines for the Netherlands during pandemic
  • Extensive environmental permits already in place will enable rapid construction
Read more
LinkedIn-button

NEED MORE INFORMATION?

Contact our
specialist

A team of 140+ specialists is at your disposal here in Bilthoven. Contact us to see how we can bring your vaccine concept ready for in-human trials.

CONTACT

Subscribe to our news update

Stay up to date with the latest developments, and be the first to receive our news updates and announcements.